Hightower Clinical LLC

1. AbbVie, Inc. $848,025 107 payments
2. Genentech, Inc. $372,776 44 payments
3. Amgen Inc. $252,082 10 payments
4. Biohaven Pharmaceutical Holding Company Ltd. $101,537 13 payments
5. Ionis Pharmaceuticals, Inc. $100,747 33 payments
6. Takeda Pharmaceuticals U.S.A., Inc. $91,895 24 payments
7. Ferring Pharmaceuticals AS $90,336 13 payments
8. Siemens Medical Solutions USA, Inc. $51,265 3 payments
9. B. Braun Medical Inc. $44,817 4 payments
10. Pfizer Inc. $43,550 9 payments

1. Roche Cancer Screening Collection Study $348,506 40 payments
2. A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn s Disease $239,016 29 payments
3. A Randomized, Double-blind, Placebo-controlled Phase 4 Clinical Trial to Evaluate the Long-term Safety and Efficacy of Avacopan in Participants With Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis $153,988 2 payments
4. M14-675 $117,216 8 payments
5. M16-006 $102,590 11 payments
6. Is354cs15 $84,152 20 payments
7. M15-991 $81,465 12 payments
8. A Phase 2/3 Randomized Double-Blind Placebo Controlled Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention $79,159 11 payments
9. M23-784 - A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn s Disease $64,491 4 payments
10. A Phase 23 Randomized Doubleblind Placebo Controlled Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention $50,928 6 payments

1. Patient care $15,700 1 payment

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.